Bogart Wealth’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6
Closed -$28 – 2159
2026
Q2
$28 Hold
6
– – ﹤0.01% 1978
2026
Q1
$39 Hold
6
– – ﹤0.01% 1779
2025
Q4
$35 Hold
6
– – ﹤0.01% 1571
2025
Q3
$26 Hold
6
– – ﹤0.01% 1521
2025
Q2
$29 Hold
6
– – ﹤0.01% 1440
2025
Q1
$34 Hold
6
– – ﹤0.01% 1391
2024
Q4
$48 Buy
+6
New +$33 ﹤0.01% 1332

Other funds holding UNCY

Bogart Wealth's UNCY Position: Q3 2026 in Review

Bogart Wealth sold out of Unicycive Therapeutics (UNCY) in Q3 2026, closing a stake of 6 shares — an estimated $28 sold.

Bogart Wealth first reported a position in UNCY in Q4 2024 and held it in 7 quarters. The position peaked at $48 in Q4 2024. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Bogart Wealth reported no remaining Unicycive Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Bogart Wealth sold 6 Unicycive Therapeutics shares in Q3 2026, an estimated $28.
  • Bogart Wealth first reported a position in Unicycive Therapeutics in Q4 2024 and held it in 7 quarters.
  • Bogart Wealth's Unicycive Therapeutics position peaked at $48 in Q4 2024.
  • 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.